Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.99 +4.89%
Financial Fact:
Interest and investment income: -950K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest and investment income: -950K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q1 EPS of $0.91, $0.14 better than the analyst estimate of $0.77. Revenue for the quarter came in at $467.3 million versus the consensus estimate of $428.46 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- UBS Downgrades Converge ICT Solutions Inc (CNVRG:PM) to Neutral
- Wolfe Research sees CNH stock flat 2027 outlook on commodity prices
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
